Technical Analysis for RGS - Regeneus Ltd  

Grade Last Price % Change Price Change
grade F 0.079 -8.14% -0.007
RGS closed down 8.14 percent on Friday, August 16, 2019, on 15 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical RGS trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -8.14%
Narrow Range Bar Range Contraction -8.14%
Wide Bands Range Expansion -8.14%
Oversold Stochastic Weakness -8.14%
MACD Bearish Centerline Cross Bearish -8.14%
Narrow Range Bar Range Contraction -8.14%

Older signals for RGS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Interactive chart
Profile
Regeneus Ltd is a clinical-stage regenerative medicine company. The Company is engaged in developing cell-based therapies for human and animal health markets, with a focus on osteoarthritis and musculoskeletal disorders, as well as oncology and dermatology diseases. The Company's portfolio of therapeutic products is being developed using stem cell and immune oncology technology platforms. The Company's technology platform includes approximately three platforms across both human and animal health businesses, including Human and animal adipose-derived mesenchymal stem cells (MSCs) for the treatment of musculoskeletal diseases; Human and animal immunotherapy personalized cancer vaccine for the treatment of various cancers, and Stem cell secretions cell free supernatant (CFS) technology harnessing the therapeutic potential of mesenchymal stem cells for skincare treatments. The Company's products include Kvax, CryoShot, Progenza, Human Cancer Vaccine and Secretions Cream.
Biotechnology Cancer Biology Life Sciences Stem Cells Cancers Regenerative Medicine Cell Biology Induced Stem Cells Mesenchymal Stem Cell Therapeutic Products Immunotherapy Stem Cell Therapy
Is RGS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.27
52 Week Low 0.06
Average Volume 137,083
200-Day Moving Average 0.1422
50-Day Moving Average 0.0912
20-Day Moving Average 0.0912
10-Day Moving Average 0.0893
Average True Range 0.006
ADX 13.83
+DI 35.4167
-DI 47.549
Chandelier Exit (Long, 3 ATRs ) 0.092
Chandelier Exit (Short, 3 ATRs ) 0.08800000000000001
Upper Bollinger Band 0.1076
Lower Bollinger Band 0.0748
Percent B (%b) 0.13
BandWidth 35.964912
MACD Line -0.0012
MACD Signal Line 0.0001
MACD Histogram -0.0013
Fundamentals Value
Market Cap 16.5 Million
Num Shares 209 Million
EPS 0.02
Price-to-Earnings (P/E) Ratio 4.94
Price-to-Sales 2.70
Price-to-Book 3.33
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.079
Resistance 3 (R3) 0.079 0.079 0.079
Resistance 2 (R2) 0.079 0.079 0.079 0.079
Resistance 1 (R1) 0.079 0.079 0.079 0.079 0.079
Pivot Point 0.079 0.079 0.079 0.079 0.079
Support 1 (S1) 0.079 0.079 0.079 0.079 0.079
Support 2 (S2) 0.079 0.079 0.079 0.079
Support 3 (S3) 0.079 0.079 0.079
Support 4 (S4) 0.079